2.5-Dimethoxy 4 Iodoamphetamine

£422.00£1,200.00

At Hounch Cannabis shop we’re the best place to get Vape Pens,
Research Chemicals,PillsMushrooms,shrooms grow kits, weed strains,
CBD/THC edibles,vape carts and cannabis products In the UK
100% safe and secure Delivery to All Locations in the UK and Across Europe.
We work 24/7 just to satisfy our clients

Clear

Description

Description

2.5-Dimethoxy 4 Iodoamphetamine(DOI) Online Two primary animal models persist for assessing hallucinogenic potential of novel compounds and for examining the pharmacological and neurological substrates underlying the actions of classical hallucinogens. the two-lever drug discrimination procedure and the drug-induced head-twitch response (HTR) in rodents 2.5-Dimethoxy 4 Iodoamphetamine(DOI) Online.

Buy 2.5-Dimethoxy 4 Iodoamphetamine(DOI) Online

Synthesizing classic, recent, and relatively overlooked findings, addressing ostensibly conflicting observations and considering contemporary theories in receptor and behavioural pharmacology.

this review provides an up-to-date and comprehensive synopsis of DOI and the HTR model, from neural mechanisms to utility for understanding psychiatric diseases.  Copyright  2012 John Wiley & Sons, Ltd.

Buy 2.5-Dimethoxy 4 Iodoamphetamine(DOI) for sale

When we wish to optimize emergency services, the first step is to analyze feedback – i.e. compare and contrast different points of view and other past experiences [DOM 05].  For example, risk prevention plans (PPR) closely examine major dangers, but are quite poor in terms of health data available to optimize the efficiency of the emergency services.

Action in times of crisis. Our findings demonstrate that DOI blocks ethanol place conditioning and selectively reduces voluntary ethanol consumption. This may be related to modulation of the effects of ethanol in the reward circuitry of the brain, ethanol-induced.

As ginsenoside Re (GRe) is well-known as a novel antioxidant in the nervous system, we investigated whether GRe modulates 5-HT2A receptor agonist DOI-induced serotonin impairments. We proposed that protein kinase Cδ (PKCδ) mediates serotonergic impairments. Our results suggest that PKCδ is a therapeutic target for GRe against serotonergic behaviors induced by DOI.

Additional information

Dosage

100g, 500g, 50g

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.